OpenAlex
PricingAboutJobs
Log inGet started
Work

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor

HTML

Year: 2015
Type: review
Source: Diabetes and Vascular Disease Research
DOI: 10.1177/1479164114563304
Authors: Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands
Institutions: Lexicon Pharmaceuticals (United States), Baylor College of Medicine
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: sotagliflozin, SGLT1 inhibition, SGLT2 inhibition, diabetes treatment, postprandial blood glucose, glucagon-like peptide-1, urinary glucose excretion, type 1 diabetes, type 2 diabetes
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1978189564
FWCI: 1.888
Cites: 30
Cited by: 134
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security